| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
26 |
25 |
$0.00 |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
25 |
24 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$0.00 |
| 99072 |
|
13 |
13 |
$0.00 |
| 99001 |
|
12 |
12 |
$0.00 |
| Q0240 |
Injection, casirivimab and imdevimab, 600 mg |
16 |
15 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
19 |
18 |
$0.00 |